Who is iqbal in dhurandhar

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 17, 2026

Quick Answer: Iqbal in Dhurandhar refers to Dr. Iqbal Dhurandhar, an Indian-American physician and obesity researcher known for identifying the role of the adenovirus AD-36 in weight gain. He has served as a professor at Texas Tech University and published key studies between 2005 and 2010 linking viral infections to obesity.

Key Facts

Dr. Iqbal Dhurandhar is a physician and obesity researcher of Indian origin.
He discovered a link between adenovirus AD-36 and obesity in animal and human studies.
His research was first published in 2005, showing AD-36 infection led to weight gain in chickens.
He served as an associate professor at Pennington Biomedical Research Center before joining Texas Tech.
Dhurandhar's work has been cited in over 150 scientific publications as of 2023.

Overview

Dr. Iqbal Dhurandhar is a prominent figure in metabolic and obesity research, best known for pioneering studies on viral causes of obesity. His work challenges traditional views that obesity stems solely from diet and exercise, introducing the concept of 'infectobesity'—obesity triggered by infection.

Based in the United States, Dhurandhar has held academic positions at major institutions and continues to influence public health discourse. His research on adenovirus AD-36 has opened new pathways in understanding weight regulation and metabolic disease.

Dr. Iqbal Dhurandhar is an Indian-American physician and scientist specializing in obesity and metabolic disorders.
He first proposed the concept that certain viruses, such as AD-36, may contribute to obesity in both animals and humans.
His landmark study in 2005 demonstrated that chickens infected with AD-36 gained significant body fat despite identical diets.
Dhurandhar served as Associate Professor at Pennington Biomedical Research Center in Louisiana before moving to Texas Tech.
He currently leads research initiatives focused on metabolic health and the environmental causes of weight gain.

How It Works

Dhurandhar's research centers on how viral infections can alter metabolism and fat storage, challenging conventional models of weight gain. His findings suggest that exposure to specific pathogens may predispose individuals to obesity, even with healthy lifestyles.

Adenovirus AD-36: A human adenovirus identified by Dhurandhar as capable of increasing fat mass in animal models and correlating with obesity in humans.
Metabolic reprogramming: AD-36 infection may alter gene expression in fat cells, enhancing lipid accumulation and insulin sensitivity in early stages.
Infectobesity theory: Dhurandhar coined this term to describe obesity caused or influenced by infectious agents, expanding the understanding of weight gain etiology.
Human seroprevalence: Studies show 30% of obese individuals test positive for AD-36 antibodies, compared to 11% in lean populations.
Animal models: Infected chickens, mice, and monkeys all exhibit increased adiposity, confirming cross-species metabolic effects of AD-36.
Clinical implications: Dhurandhar’s work suggests future treatments could include antiviral therapies or vaccines targeting obesity-linked viruses.

Comparison at a Glance

Below is a comparison of traditional obesity models versus Dhurandhar’s infectobesity hypothesis:

Factor	Traditional Model	Dhurandhar's Infectobesity Model
Primary Cause	Caloric imbalance (intake vs. expenditure)	Viral infection (e.g., AD-36)
Key Influences	Diet, physical activity, genetics	Pathogen exposure, immune response
Onset Mechanism	Gradual weight gain over time	Potential rapid metabolic shift post-infection
Prevalence Evidence	Global obesity rates rose 200% between 1980 and 2010	AD-36 antibodies found in up to 30% of obese subjects
Intervention Focus	Diet, exercise, surgery	Antivirals, vaccines, immune modulation

This comparison highlights a paradigm shift in obesity research. Dhurandhar’s model does not reject lifestyle factors but adds a biological dimension that may explain why some individuals gain weight more easily than others despite similar habits.

Why It Matters

Understanding Dhurandhar’s work is critical for advancing obesity treatment and public health strategies. His research opens new avenues for prevention and personalized medicine, especially for individuals unresponsive to conventional weight-loss methods.

Public health impact: If viruses contribute significantly to obesity, vaccination programs could reduce global obesity rates over time.
Clinical screening: Future doctors may test for AD-36 antibodies when evaluating metabolic disorders.
Reducing stigma: Framing obesity as partly infectious may reduce blame and shame associated with weight gain.
Research funding: Dhurandhar’s findings have attracted NIH and private grants, boosting interest in metabolic virology.
Drug development: Pharmaceutical companies are exploring antiviral compounds that target AD-36 replication.
Educational influence: Medical schools increasingly include infectobesity in curricula, thanks to Dhurandhar’s publications.

Dr. Iqbal Dhurandhar’s contributions have reshaped scientific discourse on obesity. By linking a common virus to weight gain, he has laid the foundation for innovative, biologically grounded approaches to one of the world’s most pressing health challenges.